Mitsui Chemicals (4183) Q4 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2026 earnings summary
18 May, 2026Executive summary
Operating income before special items for FY 2025 was JPY 100.0 billion, down JPY 1.0 billion year-on-year, mainly due to Basic & Green Materials underperformance despite growth in specialty chemicals and ICT Solutions.
Net income attributable to owners was JPY 34.4 billion, up 6.6% year-on-year, with basic EPS at JPY 91.62 after a two-for-one stock split.
FY 2026 outlook projects operating income before special items at JPY 105.0 billion, up 5.0 billion, and net income at JPY 45.0 billion, up 30.9%.
Comprehensive income surged to JPY 79.7 billion, driven by significant gains in other comprehensive income.
Financial highlights
FY 2025 sales revenue was JPY 1,668.8 billion, down 8% year-on-year, mainly due to lower naphtha prices and business withdrawals.
Specialty chemicals domains operating income before special items rose to JPY 122.1 billion, up 5% year-on-year, driven by ICT Solutions.
Basic & Green Materials posted an operating loss before special items of JPY 18.4 billion, worsened by low operating rates, inventory losses, and maintenance.
Non-recurring items totaled -JPY 26.2 billion, including impairment losses and restructuring costs.
Free cash flow was JPY 78.2 billion, with operating cash flow at JPY 213.0 billion and investing cash flow at -JPY 134.8 billion.
Outlook and guidance
FY 2026 sales revenue expected at JPY 1,900.0 billion, up 13.9%, driven by yen depreciation and higher raw material prices.
Operating income before special items forecast at JPY 105.0 billion, net income at JPY 45.0 billion.
Specialty chemicals domains operating income before special items projected at JPY 130.0 billion, up 6%.
Basic & Green Materials operating loss before special items expected to improve to JPY 3.0 billion.
Dividend outlook maintained at JPY 75 per share, with a two-for-one stock split effective January 1, 2026.
Latest events from Mitsui Chemicals
- JSR deal aims to make ICT the lead profit engine, targeting ¥300bn+ FY30 core profit.4183
Corporate presentation - H1 earnings surged, guidance rose, and the ¥1.84tn JSR deal reset growth and funding plans.4183
Q2 2027 - FY2024 guidance targets a rebound to ¥125.0bn in operating income before special items.4183
Q4 2024 - Ambitious 2030 targets leverage ESG, DX, and AI for sustainable growth and operational excellence.4183
ESG presentation - Operating income before special items jumped 88% YoY in 1Q FY2026, led by specialty chemicals and restructuring.4183
Q1 2027 - Specialty chemicals lead profit growth as global expansion and sustainability accelerate.4183
Investor presentation - Profits fell on Basic & Green Materials weakness, but ICT Solutions and capital returns remain strong.4183
Q3 2026 - Strong YoY growth with positive outlook, but Osaka plant outage adds uncertainty.4183
Q1 2025 - FY2025 profit rebound is forecast despite net income drop and trade policy risks.4183
Q4 2025